glutathione pathway to triple negative cancer The crosstalk between metabolism and non-coding RNAs in progression and treatment resistance GSTP1 Is a Driver of
GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Oncology Letters NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Glutathione Synthesis in Cancer Cells Biochemistry (Moscow) Springer Nature Link
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18




